Study Uncovers How Immune Cells Contribute to Failed Bone Healing After Muscle-Bone Trauma
CHENGDU, SICHUAN, CHINA, July 21, 2025 / EINPresswire.com / -- Gaining insights into the complex pathways and key cell populations involved in immune dysregulation can aid the development of therapeutic approaches to treat polytrauma, which is associated with poor patient outcomes. In a new study, researchers from the USA have utilized advanced genetic analysis tools and techniques to reveal the cellular and molecular processes involved in polytrauma-induced immune dysregulation. Their findings advance our current knowledge on polytrauma and indicate actionable targets to treat immune dysregulation.
Polytrauma, which involves multiple serious injuries occurring simultaneously, is associated with complex healing challenges. In such cases, bone regeneration is often compromised, accompanied by widespread immune system dysregulation. These effects may not surface immediately, but they commonly emerge later in recovery, contributing to increased treatment burden and poorer long-term outcomes.
While the immune system plays a crucial role in healing, its dysfunction in polytrauma remains poorly understood. Previous studies have explored immune activity either at the injury site or within systemic tissues like blood and bone marrow. However, an integrated analysis of both local and systemic immune responses is essential to fully understand how immune dysregulation impairs recovery.
To address this gap, a team of researchers led by Professor Krishnendu Roy, Bruce and Bridgitt Evans Dean of Engineering at Vanderbilt University, conducted a comprehensive study using single-cell RNA sequencing (scRNA-seq). The research team, based at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology, collaborated with Professor Robert Guldberg from the Department of Bioengineering and Knight Campus for Accelerating Scientific Impact at the University of Oregon. This work was supported by a National Institutes of Health grant (R01AR074960). Their findings were published online in Bone Research on 07 July, 2025.
'Previously, our research group had developed a preclinical rat model of polytrauma that could mimic severe musculoskeletal trauma along with the associated local and systemic immune responses. In this study, we utilized cells from the polytrauma rat model and subjected them to scRNA-seq analysis to comprehensively assess the cellular and molecular mechanisms that drive immune dysregulation in polytrauma', says Prof. Roy, sharing further details about the study.
The team combined scRNA-seq with differential gene expression (DEG) analysis, gene set enrichment analysis (GSEA), and the CellChat tool to identify the key immune cells involved. Their analysis revealed a prominent role of myeloid cells—a type of white blood cell—in shaping immune responses across the blood, bone marrow, and injured tissue.
Building on their previous findings linking systemic immunosuppressive myeloid cells with poor bone healing outcomes, the researchers sub-clustered the blood polytrauma myeloid cells into five distinct groups to identify those expressing immunosuppressive genes such as interleukins-4 (IL-4), IL-13, and IL-10. The clusters expressing these immunosuppressive genes were designated as trauma immunosuppressive myeloid (TIM) cells. Further DEG analysis revealed that TIM cells from polytrauma patients significantly expressed additional immunosuppressive genes, including annexin A1 (Anxa1) and nitric oxide synthase 2 (Nos2).
To decipher the pathways used by TIM cells to communicate with other myeloid cells, the team assessed ligand-receptor interactions using CellChat tool. Their analysis revealed that TIM cells were dependent on chemokine pathway involving Ccl6-Ccr1 and immunosuppressive Anxa1-Fpr2 mechanisms to communicate with other cells in polytrauma blood.
In the local injury site tissue affected during polytrauma, mono/mac cells demonstrated increased expression of pro-inflammatory genes including secreted phosphoprotein 1 (SPP1), fibronectin 1 (FN1), and Anxa2. Interestingly, the mono/mac cells showed reduced expression of tissue repair genes following polytrauma. By utilizing an integrated all-tissue dataset, the research team further discovered 15 closely connected hub genes which could potentially regulate polytrauma-induced immune dysregulation.
The altered communication patterns in polytrauma reveal the critical role of myeloid cell interactions, with TIM cells involved in immune suppression while mono/mac cells drive inflammatory pathways. Future studies can build on our findings to develop targeted strategies to modulate immune responses, reduce complications, and ultimately improve clinical outcomes in patients with polytrauma. Towards that goal, a multi-site clinical study to risk stratify patients with open tibial fractures has been initiated by Prof. Guldberg and colleagues.
In summary, this study not only advances our current understanding of complex immune interactions following polytrauma but also provides actionable targets for therapeutic intervention.
***
Reference
Title of original paper: Single-cell transcriptomic analysis identifies systemic immunosuppressive myeloid cells and local monocytes/macrophages as key regulators in polytrauma-induced immune Dysregulation
Journal: Bone Research
DOI: 10.1038/s41413-025-00444-x
Yini Bao
West China School of Stomatology, Sichuan University
+86 2885546461
[email protected]
Visit us on social media:
X
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
7 hours ago
- Medscape
Federal Government Funds Program for Hepatitis C Care, Cure
A new $100 million pilot program launched by the Department of Health and Human Services (HHS) offers state and community-based health care organizations the resources for prevention, testing, and treatment of hepatitis C among individuals with substance use disorder and serious mental illness, according to an HHS press release. The program, known as the Hepatitis C Elimination Initiative Pilot, will be administered by the Substance and Mental Health Administration. 'This program is designed to support communities severely affected by homelessness and to gain insights on effective ways to identify patients, complete treatment, cure infections, and reduce reinfection by hepatitis C,' according to the press release. The upfront investment in hepatitis C management is projected to not only save lives, but also to save community health care costs in the long-term, according to the press release. 'This is a vigorous pilot program that provides the first steps toward the large goal of eliminating hepatitis C in the United States population,' said William Schaffner, MD, professor of infectious diseases at Vanderbilt University Medical Center, Nashville, Tennessee, in an interview. Hepatitis C affects more than two million individuals in the US, and is often complicated by social and medical issues such as homelessness, substance abuse, and mental health issues, said Schaffner. Fortunately, hepatitis C can be treated with oral medications that cure the chronic viral infection, thereby ending ongoing liver injury and interrupting person-to-person transmission of the virus by sharing needles, he said. Given that the population most affected with hepatitis C also is often homeless, with possible mental health issues and sharing of needles for illicit drug use, challenges in reaching this population include assuring them that the care they receive though this and other programs is nonjudgemental and helpful, Schaffner told Medscape Medical News . The oral medications that now can cure the chronic hepatitis C viral infections must be taken over a period of weeks, and patients who lead socially disorganized lives often need assistance to assure that the medicine is taken as intended, so trained and sensitive personnel who are committed to helping this population are needed to make treatment programs succeed, he said. Looking ahead, 'the purpose of the pilot studies that will be funded by this program is to explore various approaches to determine which are more successful in bringing patients in to be evaluated and then to complete treatment,' Schaffner added. State and community-based organizations are among the entities eligible to apply for the program. Potential applicants can find information about the program and application materials on the SAMSHA website.
Fox News
20 hours ago
- Fox News
Biden's doctor thought cognitive tests were 'meaningless,' ex-aide Bruce Reed told investigators
Former White House physician Kevin O'Connor previously dismissed cognitive tests as "meaningless," ex-Biden administration aide Bruce Reed told House investigators on Tuesday, according to a source familiar with the proceedings. Reed, who served as White House deputy chief of staff for policy, is the ninth member of former President Joe Biden's inner circle to sit down with House Oversight Committee lawyers. A source familiar with his interview told Fox News Digital that Reed attributed Biden's disastrous 2024 debate performance against then-candidate Donald Trump to the former president's stutter, a condition that's been well-documented and Biden himself has publicly acknowledged. But his meandering and seemingly tired demeanor on stage with Trump alarmed both Democrats and media pundits, who saw it as a glaring sign of Biden's advanced age. It precipitated both a public and private push by left-wing lawmakers to get Biden to drop out of the race – which he did in July 2024. When asked whether public concerns about Biden's mental acuity were legitimate, however, the source told Fox News Digital that Reed said he believes Americans should not have had any concerns about the ex-president's mental faculties. Reed also told investigators that "the president's communications team anticipated that the issue of a cognitive test would likely be raised" in Biden's interview with ABC News host George Stephanopoulos following the debate. "Mr. Reed further explained that President Biden's physician, Dr. Kevin O'Connor, dismissed cognitive tests as 'meaningless,'" the source said. O'Connor was among the first former White House officials summoned by House investigators, and sat down with them last month after being compelled via subpoena. But his sit-down lasted less than an hour, with the doctor opting to invoke the Fifth Amendment to avoid answering all questions but his name. His lawyers said at the time that was due to concerns about violating doctor-patient confidentiality. In his own interview Tuesday, Reed also defended the Biden 2024 campaign's preference to hold the debate earlier than typical for a presidential cycle, the source said. "During his interview, Mr. Reed stated that the decision to hold the debate early was a deliberate strategy to get ahead of early voting and the Olympics. He emphasized that the campaign's push for the early debate was unrelated to concerns about President Biden's age," the source said. Excerpts of Reed's opening statement to investigators, obtained by Fox News Digital via a second source familiar with the interview, show he emphatically defended Biden's cognitive abilities. "While I can only speak to my own observations, I had the benefit of working with President Biden nearly every day of his presidency. Despite his age, President Biden maintained an unrelenting work ethic, embraced complex policy issues, and approached decisions with diligence and deliberation," Reed said, according to the source. Reed also described Biden as "a demanding boss who routinely grilled staff members on a topic until he reached the limits of our knowledge so he could judge whether to have confidence in our advice," though "that didn't mean he'd take it." "From the first days in the White House to the last, President Biden governed the same way he'd gotten there, by trusting his own values and instincts," Reed said, according to the source. "There is no tougher test than the presidency: President Biden asked tough questions, made tough decisions, and led his country well in challenging times for the nation and the world." Chairman James Comer, R-Ky., is probing whether Biden's senior aides worked to cover up evidence of mental decline in the former president, and whether that meant Biden was not making the final decision on executive matters signed by autopen. Of particular interest to Comer is the myriad of clemency orders Biden signed in the latter half of his presidency, though the former president told The New York Times last month that he was behind every decision. His allies have also dismissed Comer's probe as purely political. Fox News Digital reached out to Reed's counsel and lawyers for O'Connor for comment but did not hear back by press time.
Yahoo
6 days ago
- Yahoo
Always Unwell? A Huge New Study Suggests It Could Be Your Sleep Schedule
If you're always a little under the weather or find that you are more susceptible to illness than your peers, it may actually be because of your sleeping habits. A new study published in Health Data Science, analysed sleep data from 88,461 adults in the UK Biobank and found significant associations between sleep traits and 172 diseases including liver cirrhosis and gangrene Eek. The good news is, if you prefer to sleep for longer periods of time, you're still safe as the researchers state: 'Contrary to common belief, sleeping more than 9 hours wasn't found to be harmful when measured objectively, exposing flaws in previous research.' The real secret to better health is you sleep 'Our findings underscore the overlooked importance of sleep regularity,' said Prof. Shengfeng Wang, senior author of the study. 'It's time we broaden our definition of good sleep beyond just duration.' While sleep quality and duration can play a part, irregular sleeping patterns were the biggest sleep factor to disease – accounting for a startling 23% of the diseases linked to sleep. Researchers from Vanderbilt University reported that participants in the most irregular quartile faced a 53 percent higher risk of dying over eight years, even after adjusting for age, BMI, and existing illness. Sleeping after 12:30 a.m. was linked to a 2.57-fold higher risk of liver cirrhosis and inconsistent sleep-wake cycles more than doubled the risk of gangrene. Neuroscientist Dr Matt Walker said on the Huberman Lab podcast: 'Regularity is probably best for the continuity of your sleep. 'When you give [your brain] regularity, sleep starts to become more stable, more stable means that it's less likely to be littered with awakenings, meaning that it's better quality of sleep.' How to improve your sleep regularity The sleep experts at The Sleep Foundation advise: 'Pick a bedtime and wake-up time that you can stick with and that offer ample time for the sleep you need. Follow this schedule every day, even on weekends. It may take time to adjust to this new sleep schedule, which is normal. ' If you would prefer to gradually adapt to a new schedule, you can make 15 to 30 minute adjustments over a series of days to get used to the changes. They also recommend that your sleeping pattern should: Stay consistent from day-to-day Allow for at least seven hours of sleep each night Align as closely with day and night as your lifestyle allows Related... I Thought We Needed To Sleep Apart – Then Came The Scandinavian Method I'm A Sleep Expert – This 1 Change In Teens Can Be A 'Big Shock' For Parents Neurologist Shares The 1 Sleep Change That Could Reduce Dementia Risk
